Magnesium sulfate: Severe hypocalcaemia secondary to hypermagnesaemia following drug exposure during pregnancy.

Author InformationAn event is serious (based on the ICH definition) when the patient outcome is:• * death * life-threatening * hospitalisation * disability * congenital anomaly * other medically important eventA woman in her 20s developed severe hypocalcaemia secondary to hypermagnesaemia during treatment with magnesium sulfate for fetal neuroprotection during pregnancy. [Extracted from the article]